SCHOFIELD, Wis., Sept. 28, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), has announced that it will host a shareholder conference call on Wednesday, Sept. 29, 2010, at 4:10 p.m. EDT (3:10 p.m. CDT) to discuss year-end financial results. The call will begin with a 15-minute presentation followed by a Q&A session.
Participation in the call is open to all interested parties. Participants may use the following phone numbers to take part in the call. Within the U.S. and Canada dial (Toll Free): 877-407-9210.International participants can dial: 201-689-8049. A live webcast will also be available at http://www.investorcalendar.com/IC/CEPage.asp?ID=161840. Participants will be asked to provide the following conference ID number:357840. A replay will be made available. To access the replay, visit www.PuraMedBioScience.com.
A full set of financial statements will be available at .
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic™ M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic™ PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic™ H for common tension headaches. For more information on PuraMed, visit the Company website at , join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at .
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
CONTACT: PuraMed BioScience, Inc. Russell Mitchell, Chairman and CEO 715-359-6373 rmitchell@PuramedBioScience.com www.PuramedBioScience.com Investor Awareness, Inc. Investor Relations: Tony Schor James Foy 847-945-2222 www.investorawareness.com North Shore Public Relations, Inc. Media Contact: Renae Placinski 847-945-4505 Renae@northshorepr.com www.northshorepr.com